Eye cancer treatment with chemotherapy

Today chemotherapy remains one of the best ways to treat advanced stages of eye cancer, especially if medical practitioners discover distant metastases in the patient's body. The active components of chemo drugs reach out to the cancerous cells and destroy them, shrinking the primary tumor and decreasing the number and size of cancerous lesions. Unfortunately, due to the systemic nature of the treatment effect, chemo medications might also have some bad influence on the healthy tissues and organs of the organism. Medical practitioners must conduct a deep examination of the current patient's health condition to have a high chance of ending the chemotherapy course and successfully achieving great treatment results. Currently, oncologists use dozens of different medications during the chemotherapy of patients with eye cancer, including nivolumab, ipilimumab, and pembrolizumab. The schemes and dosages of drugs significantly vary depending on the patient's condition, cancer features, stage, and other factors. A single treatment procedure usually takes up to a few hours. Most medications are delivered via droppers or intravenous injections. Still, oral administration forms (like pills or capsules) might also be used. The number of procedures in a single course of chemotherapy for eye cancer starts somewhere from 4-8 and might reach up to 10-12.